Innovation Pharmaceuticals Inc (IPIX)

[Waverunner1]

Excellent post, I agree wholeheartedly with everything you said except for this statement --

Kevetrin is extremely promising but it's a very long road.

In terms of payoff it doesn't have to be. Successful Phase 2 trials are generally the inflection point where biotech stock valuations can go parabolic. (There are a number of examples of multi-billion dollar market caps attained in Phase 2/prior to Phase 3). With Phase 2 for AML starting soon and Phase 2 for solid tumors likely firing up next year, CTIX could soon find itself in a very enviable (and profitable) position. With stellar results, or if either halts early for efficacy, the stock of a successful P53 activating drug will be in low earth orbit. And of course in that case you would see an expedited time to market as well. The name escapes me at the moment but I believe the record for a cancer drug is 3 yrs from Phase I to approval. And regulatory obstacles seem to be moderating significantly going forward.